Exercise May Ease Craving in Substance Use Disorders, but Abstinence Gains Remain Unproven
Exercise is increasingly being studied as an adjunct for adults living with substance use disorders, yet the evidence base has been difficult to interpret because reviews overlap, trials are small, and outcomes vary widely across studies. This updated umbrella review attempted to bring order to that literature by examining clinically important, patient-important, and implementation outcomes across a broad set of systematic reviews, including tobacco and nicotine dependence.
The central message is simple and clinically consequential. Exercise appears capable of shifting short-term craving and some cognitive outcomes, but the data do not yet support a claim that it reliably prevents relapse or produces durable abstinence.
Craving Fell After Exercise, Especially in Tobacco and Drug Use Studies
Investigators searched 10 databases through 24 September 2026 and retained 47 systematic reviews. Forty-five of those reviews yielded recoverable primary-report lists, allowing the team to map 353 unique report keys across 785 report occurrences. The overlap was low, with a corrected covered area of 2.78%, but the broader evidence still reflected the familiar problem of multiple reviews drawing from a fragmented trial literature.
Three estimates stood out because conventional confidence intervals, modified Knapp–Hartung intervals, and prediction intervals all excluded the null. Tobacco craving measured 10 minutes after exercise favored intervention with a standardized mean difference of –0.80, 95% confidence interval –1.04 to –0.57. Drug craving at the end of exercise programs lasting at least four weeks also favored exercise, with a standardized mean difference of –0.75, 95% confidence interval –0.93 to –0.56. Inhibitory control improved as well, with a standardized mean difference of 0.48, 95% confidence interval 0.29 to 0.67.
Those findings fit a biologically plausible pattern. Acute physical activity may temporarily dampen cue-driven urge states, alter stress reactivity, and sharpen executive control at exactly the moment when craving is most likely to trigger use. In a disorder marked by reward dysregulation and impaired top-down control, even brief improvements in inhibitory control could matter at the bedside if they translate into better coping during high-risk windows.
Exercise did not behave like a stand-alone anti-addiction therapy. It behaved more like a short-acting behavioral modulator of drive and control.
Abstinence Signals Were Small and Too Uncertain for Practice Change
Tobacco abstinence showed small average benefits, but the prediction intervals still included no benefit. That matters because prediction intervals ask a more uncomfortable question than a standard pooled estimate: what might happen in a new setting, with new clinicians, new participants, and a new intervention design? Here, the answer remains unsettled.
Evidence for relapse, treatment retention, and safety was insufficient for reliable study-level synthesis. In a field where the most important outcome is often whether a patient continues using less, stops using, or stays engaged in treatment long enough to benefit from it, the absence of dependable pooled estimates limits any claim that exercise can do more than support symptoms in the short term.
The review’s certainty ratings reinforce that caution. Forty outcome-specific GRADE judgments were made: one moderate, 13 low, and 26 very low. In practical terms, the apparent gains are sitting on a thin evidentiary base. Small trials, heterogeneous exercise prescriptions, mixed comparators, and variable outcome definitions all increase the risk that a seemingly favorable estimate will shrink or disappear when larger, more rigorous trials arrive.
Why the Signal Is Real but Still Fragile
The response to exercise in addiction treatment is likely to be partly behavioral and partly neurobiological. Structured movement can reduce withdrawal-associated distress, occupy attention during craving spikes, and improve mood or sleep, all of which may lower the chance of immediate use. Physical exertion may also influence catecholamine tone, stress systems, and frontostriatal control networks that are central to compulsive substance seeking.
Still, a plausible mechanism is not the same as a durable clinical effect. Short-lived reductions in craving can be meaningful, especially when they create enough breathing room for counseling, contingency management, or medication treatment to work more effectively. Yet the review does not show that exercise reliably produces the kind of outcome that matters most to patients and clinicians: fewer relapses, sustained abstinence, and continued treatment engagement.
The distinction is especially important because exercise interventions are often attractive to patients who want something active, self-directed, and nonpharmacologic. That appeal should not be confused with proof of efficacy across the full addiction treatment pathway.
What the Evidence Base Can Support Right Now
The review supports a restrained but useful conclusion: exercise may improve selected craving and cognitive outcomes in adults with substance use disorders, but the evidence is predominantly low or very low certainty. The most defensible role for exercise at this stage is as an adjunct to established treatment, not as a replacement for medication, counseling, or other evidence-based care.
A final point is worth holding onto. Even the strongest signals in this literature were concentrated in proximal outcomes, not in the endpoints that decide long-term recovery. Until larger, better-registered studies report relapse, retention, and safety with enough consistency for robust synthesis, exercise should be viewed as a potentially helpful component of comprehensive care rather than a proven anti-relapse intervention.
Evidence Gaps Still Define the Field
Several blind spots remain. Safety could not be synthesized reliably, despite the clinical importance of understanding whether exercise is tolerable, feasible, and sustainable in this population. The review also could not resolve how different exercise intensities, durations, settings, or supervision models compare with one another. Those are not minor design details; they determine whether a program can be delivered in addiction clinics, community settings, or alongside residential treatment.
The most consequential unanswered issue is not whether exercise can move craving scores on a good day. It is whether those score changes translate into fewer episodes of use, better retention in care, and measurable recovery over time. The current evidence does not answer that question yet.